$6.52
-26.57% past month
Notable price movement
Oct 23, 2026
$6.56-0.46%
QUBT closed down 0.46% while comparable Services-Prepackaged Software companies rose 1.31% on average, with 5 of 6 rising . The decline was therefore not shared by the cohort. Volume was 0.6x the trailing 20-session average, and the session range was 3.5% of the low .
Oct 22, 2026
$6.59-3.37%
Comparable Services-Prepackaged Software companies rose 1.53% on average, with 4 of 6 higher, while this stock fell 3.37% . The decline was not shared by the peer group.
Oct 21, 2026
$6.82+4.92%
Comparable Services-Prepackaged Software companies rose 2.09% on average, with all 6 higher . QUBT's 4.92% gain came alongside that sector advance and was larger than the cohort average .
Oct 20, 2026
$6.50+1.25%
Comparable Services-Prepackaged Software companies rose 3.33% on average, with none of the 6 falling . QUBT rose 1.25%, a smaller gain than the cohort average . The Motley Fool published a piece on pure-play quantum computing stocks, including QUBT, but its argument is not treated as an explanation here .
Oct 19, 2026
$6.42+0.94%
Comparable Services-Prepackaged Software companies rose 1.02% on average, with 3 of 6 falling and 3 rising . QUBT's 0.94% gain was close to that average move .
Oct 16, 2026
$6.36-7.02%
Comparable listed companies in Services-Prepackaged Software fell 4.97% on average on the day, with all 6 of 6 declining . QUBT's 7.02% drop came alongside that sector-wide weakness and was somewhat steeper than the cohort average .
Oct 15, 2026
$6.84+8.40%
Comparable listed companies in Services-Prepackaged Software rose 5.10% on average, with all 6 of 6 advancing . QUBT's 8.40% gain came alongside that sector-wide rise and was larger than the average .
Closing prices for QUBT. Summaries describe past sessions only and are not advice, a forecast or a recommendation.
Recent news
Headlines are published by third parties and linked as reported. Amaltash does not endorse or verify them.
Prices and financial data are historical and provided for research only. Not investment advice.